COMMUNIQUÉS West-GlobeNewswire

Pacific Biosciences Prevails in Patent Eligibility Ruling Against Oxford Nanopore
22/03/2018
MENLO PARK, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB ), the leader in long-read, high-resolution sequencing, today announced that Judge Leonard P. Stark of the U.S [...]
ARCA biopharma Announces Fiscal Year 2017 Financial Results and Provides Corporate Update
22/03/2018
WESTMINSTER, Colo., March 22, 2018 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO ), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for [...]
Emergent BioSolutions to Implement Stock Repurchase Program for up to $50 Million of Its Common Stock
22/03/2018
GAITHERSBURG, Md., March 22, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) today announced that its Board of Directors has authorized the company’s management to implement a stock repurchase program [...]
Atara Biotherapeutics to Participate in Three Upcoming Immuno-Oncology Conferences
22/03/2018
SOUTH SAN FRANCISCO, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]
Progenics Pharmaceuticals Announces Three-Month Extension of PDUFA Date for AZEDRA® (iobenguane I 131)
22/03/2018
NEW YORK, March 22, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, [...]
Caladrius Biosciences Reports 2017 Fourth Quarter and Year End Financial Results
22/03/2018
BASKING RIDGE, N.J., March 22, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
Leap Therapeutics Announces Proposed Public Offering of Common Stock
22/03/2018
CAMBRIDGE, Mass., March 22, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ: LPTX ), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it has [...]
Cesca Therapeutics Announces Financial Results for the Transition Period July 1, 2017 to December 31, 2017, and Provides Corporate Update
22/03/2018
RANCHO CORDOVA, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced [...]
Marrone Bio Innovations to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 29th at 2:00 p.m. Pacific time
22/03/2018
DAVIS, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ), (MBI) a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and [...]
Medigus Ltd Announces Fourth Quarter and Fiscal Year 2017 Financial Results
22/03/2018
OMER, Israel, March 22, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”) (NASDAQ: MDGS ) (TASE: MDGS ), a medical device company developing minimally invasive endosurgical tools and an innovator in [...]
OrthoPediatrics Corp. Introduces PediFlex™ Advanced Surgical System
22/03/2018
WARSAW, Ind., March 22, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the introduction of PediFlex [...]
Altimmune to Participate at the H.C. Wainwright Global Life Sciences Conference
22/03/2018
GAITHERSBURG, Md., March 22, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, announced today that Bill Enright, President and Chief Executive Officer, will provide a [...]
HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2017 Results
22/03/2018
Revenue increased 442% and 188%, respectively, compared to the three and twelve month periods in the prior year driven by development efforts supporting Pharma clinical programs TUCSON, Ariz., March 22, 2018 (GLOBE [...]
iCAD Reports Fourth Quarter and Full-Year 2017 Financial Results
22/03/2018
Fourth quarter total revenues increased 14% year-over-year; total revenues increased 22% excluding MRI asset sale Conference call today at 4:30 p.m. ET NASHUA, N.H., March 22, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ [...]
CareDx Reports Fourth Quarter and FY2017 Financial Results
22/03/2018
47 Transplantation Centers Offering AlloSure 9 Centers Enrolled in K-OAR BRISBANE, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA ), a molecular diagnostics company focused on the discovery, [...]
La Jolla Pharmaceutical Company Announces Launch of GIAPREZA™ (angiotensin II) in the United States
22/03/2018
SAN DIEGO, March 22, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC ) today announced that GIAPREZA™ (angiotensin II), injection for intravenous infusion, is now commercially available. In [...]
Title21’s CEO Lynn Fischer Shares Her Career Pivot into Healthcare Technology on THE MENTORS RADIO SHOW
22/03/2018
PLEASANTON, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Co-founder and CEO of Title21 Health Solutions ( www.Title21.com ) Lynn Fischer will share her purpose-driven career story on The MENTORS RADIO SHOW this weekend. [...]
CyberFuels, Inc. Announces Completion of GSA Application and award of CAGE number
22/03/2018
PALM BEACH, Fla., March 22, 2018 (GLOBE NEWSWIRE) -- EncounterCare Solutions, Inc. (Pink Sheets:ECSL) wholly owned subsidiary CyberFuels is pleased to announce that it has completed the registration process for [...]
Establishment Labs Receives IDE Approval from U.S. FDA to Initiate Clinical Trial of Motiva Implants®
22/03/2018
NEW YORK, March 22, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc., a global medical device company focused on breast aesthetics and reconstruction technologies with a strong emphasis on product development [...]

Pages